Aquestive Therapeutics rises after $85 million stock sale
** Drugmaker Aquestive Therapeutics' AQST.O shares rise 5.4% to $4.23
** AQST announces pricing of $85 million stock offering
** Co sold ~21.3 million shares at $4 apiece, just 0.2% discount to stock's last close
** Proceeds will be used to advance the launch and commercialization of epinephrine sublingual film for the treatment of severe, life-threatening allergic reactions and other purposes
** Offering led by RTW Investments and included participation from Samsara BioCapital, EcoR1 Capital, Perceptive Advisors, Sio Capital Management, ADAR1 Capital Management and Nantahala Capital
** Leerink Partners, Cantor, and Oppenheimer were joint bookrunning managers for the offering
** All nine brokerages covering the stock rate "buy" or higher; median PT $8 - data compiled by LSEG
** As of last close, AQST stock up 12.6% YTD
Related Articles
Investing in Clean Energy
TradingKey - Not so long ago, clean energy was relegated to a niche, a corner for subsidies, early markets, and greens. Now it's at the center of global economic thought. Governments, business, and consumers are driving a structural transformation from fossil fuels to renewables. The roofs are toppe
Investing in Luxury & Experiential Consumption
Niche assets like data centers, logistics, healthcare, and cold storage thrive on structural drivers, not traditional property cycles Specialized real estate benefits from secular trends like digitalization, demographics, and supply chain innovation, making demand resilient and less cycle-sensitive
Oracle’s FY2026 Q1 Preview: Will OpenAI Contract Spark a Broadcom-Like Stock Surge?
TradingKey - As analysts raise targets and expectations, could Oracle’s stock replicate the post-earnings rally seen at Broadcom following its OpenAI-related contract announcement?
U.S. August CPI Preview: Persistent Rise in Inflation, What Impact on Rate Cuts? And on US Stocks?
TradingKey - On 11 September 2025, the U.S. will publish August CPI data. Consensus forecasts indicate a 0.3% month-over-month increase for both headline CPI and core CPI. As a result, headline CPI year-over-year may climb to 2.9%, up from 2.7%
Fed to Cut Rates: All Asset Prices Up!
TradingKey - The Federal Reserve is almost certain to restart its interest rate cut cycle on 17 September this year. After in-depth research, we have concluded that cryptocurrencies, the broader U.S. stock market, and short-term U.S. Treasury bonds will all go up.
